Cann Group surges 44.3% on the back of loan approval
Shares in medical cannabis company Cann Group Limited (ASX: CAN) has surged 44.3% after the company announced they have secured a $50 million loan. Keep Reading
MGC Pharma buys telehealth platform Medicinal Cannabis Clinics
ASX-listed medical cannabis company MGC Pharma (ASX:MXC) has announced that the company has acquired telehealth platform Medicinal Cannabis Clinics. Keep Reading
Althea Group will be the first Australian company to sell cannabis in Germany
Australian cannabis company Althea Group (ASX:AGH) has been granted licenses by the German government to sell and distribute Australia-grown medical cannabis in Germany. Keep Reading
AusCann announces plans to acquire animal cannabis company CannPal
Medical cannabis company AusCann Group Holdings (ASX: AC8) has announced plans to buy CannPal Animal Therapeutics (ASX: CP1) for $17.5 million. Keep Reading
Martha Stewart releases Christmas-themed CBD gift box
Martha Stewart will be releasing a cannabis themed gift box this Christmas, as part of her new ‘Martha Stewart CBD’ line. Keep Reading
MMJ Group investment Harvest One increases revenue despite pandemic
Cannabis company Harvest One (CVE: HVT) has recorded an increase in revenue for the 2019-20 financial year, delivering good news to Australians with shares in cannabis investment company MMJ Group. Keep Reading
Zelira and Emyria announce medical cannabis for Autism Spectrum Disorder and medical cannabis
ASX-listed medical cannabis company, Zelira Therapeutics (ASX: ZLD), has announced they will be conducting a study into medical cannabis and Autism Spectrum Disorders with Emyria (ASX: EMD). Keep Reading
Australian Cannabis Summit is streaming live this weekend on 13th & 14th November
The Australian Cannabis Summit, usually held in Brisbane, will be streamed online, live, and free – for anyone who’s interested in medical and recreational cannabis. Keep Reading
AFT Pharmaceuticals signs an agreement with NZ cannabis supplier
ASX-listed company AFT Pharmaceuticals has announced their entrance into the medical cannabis industry, after signing an agreement with New Zealand-based cannabis company, Setek. Keep Reading
The Asia Pacific cannabis market will be worth over $22.9 billion USD by 2027
A new report published by market research firm, Reportlinker, has predicted that the Asia Pacific cannabis market will be worth over $22.87 billion USD by 2027. Keep Reading